The Centre for Molecular Biology Severo Ochoa (CBMSO) is a joint research centre, hosting researchers belonging to CSIC and UAM. Founded in 1975, under the scientific patronage of the Nobel Prize Severo Ochoa, the CBMSO has evolved into one of the largest Spanish multidisciplinary research centres in Biomedicine, gathering expertise in molecular biology, biochemistry, genetics and genomics in several areas including immunology, virology and microbiology, neuroscience, and cell and developmental biology. This broad expertise confers the centre the needed versatility to undertake new research challenges in emergent topics and unresolved biomedical problems, with a preponderant interest in the interplay between immunity, inflammation and metabolism applied to prevalent (e.g. autoimmune, cardiovascular and neurodegenerative diseases or cancer) and rare diseases and organismal aging.
With more than 450 collaborative scientists, the CBMSO stands out for its important scientific production and technology transfer to industry and clinic, supported by state-of-the-art technology provided by 8 Research Core Facilities, 9 Technical Services and 1 Innovation Unit (INNO-CBM) with >65 highly experienced personnel. The CBMSO is also highly committed to instruct early career research trainees (TRAIN@CBM) and to research communication through a pioneer Outreach Office with >20 years of experience.
The CBMSO know-how, expertise and pedigree are used to achieve strategic goals including: a) consolidate its unique scientific niche in the Spanish landscape and become an international benchmark in immunity, inflammation and metabolism research; b) incorporate young competitive researchers according to its gender and diversity plan and foster the activity of recent incorporations above international standards; c) obtain international competitive funds and attract investments from the biotech/pharmaceutical sector, according to the increasing applicability of the CBMSO research output.